VOYA Investment Management’s KalVista Pharmaceuticals KALV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Buy |
10,714
+475
| +5% | +$5.37K | ﹤0.01% | 2449 |
|
|
2025
Q1 | $118K | Sell |
10,239
-2,151
| -17% | -$24.8K | ﹤0.01% | 2396 |
|
|
2024
Q4 | $105K | Sell |
12,390
-931
| -7% | -$7.89K | ﹤0.01% | 2566 |
|
|
2024
Q3 | $154K | Sell |
13,321
-94
| -0.7% | -$1.09K | ﹤0.01% | 2556 |
|
|
2024
Q2 | $158K | Buy |
13,415
+3,125
| +30% | +$36.8K | ﹤0.01% | 2547 |
|
|
2024
Q1 | $122K | Sell |
10,290
-2,249
| -18% | -$26.7K | ﹤0.01% | 2587 |
|
|
2023
Q4 | $154K | Buy |
12,539
+2,170
| +21% | +$26.6K | ﹤0.01% | 2652 |
|
|
2023
Q3 | $99.9K | Hold |
10,369
| – | – | ﹤0.01% | 2734 |
|
|
2023
Q2 | $93.3K | Buy |
+10,369
| New | +$93.3K | ﹤0.01% | 2808 |
|
|
2021
Q2 | – | Sell |
-8,195
| Closed | -$211K | – | 2855 |
|
|
2021
Q1 | $211K | Buy |
+8,195
| New | +$211K | ﹤0.01% | 2511 |
|